Esomeprazole Strontium/Naproxen

ๅŸƒ็ดข็พŽๆ‹‰ๅ”‘้”ถ/่˜ๆ™ฎ็”Ÿ

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEsomeprazole Strontium/Naproxen
Drug Alias Name่˜ๆ™ฎ็”Ÿ/ๅŸƒ็ดข็พŽๆ‹‰ๅ”‘้”ถnaproxen+esomeprazole strontiumๅŸƒ็ดข็พŽๆ‹‰ๅ”‘้”ถ+่˜ๆ™ฎ็”Ÿesomeprazole strontium+naproxen่˜ๆ™ฎ็”Ÿ+ๅŸƒ็ดข็พŽๆ‹‰ๅ”‘้”ถ +[8]ย 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsProton pump inhibitors
TargetsProton pumpCyclooxygenases
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsArthritis, Rheumatoid
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2013/01/01
Country/TerritorySouth Korea
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeM01AE52
Related LinksN/A